Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.

Savani AA, Login IS.

Neurology. 2007 Mar 6;68(10):797; author reply 797. No abstract available.

PMID:
17339599
2.

The long-term effect of tetrabenazine in the management of Huntington disease.

Fasano A, Cadeddu F, Guidubaldi A, Piano C, Soleti F, Zinzi P, Bentivoglio AR.

Clin Neuropharmacol. 2008 Nov-Dec;31(6):313-8. doi: 10.1097/WNF.0b013e318166da60.

PMID:
19050408
3.

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.

Huntington Study Group..

Neurology. 2006 Feb 14;66(3):366-72.

PMID:
16476934
4.

Tetrabenazine in the treatment of severe pediatric chorea.

Chatterjee A, Frucht SJ.

Mov Disord. 2003 Jun;18(6):703-6.

PMID:
12784277
5.

Short-term effects of tetrabenazine on chorea associated with Huntington's disease.

Kenney C, Hunter C, Davidson A, Jankovic J.

Mov Disord. 2007 Jan;22(1):10-3.

PMID:
17078062
6.

Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.

Setter SM, Neumiller JJ, Dobbins EK, Wood L, Clark J, DuVall CA, Santiago A.

Consult Pharm. 2009 Jul;24(7):524-37. Review.

PMID:
19689181
7.

Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus.

Sitburana O, Ondo WG.

Mov Disord. 2006 Nov;21(11):2023-5.

PMID:
16986158
8.

Tetrabenazine: for chorea associated with Huntington's disease.

Scott LJ.

CNS Drugs. 2011 Dec 1;25(12):1073-85. doi: 10.2165/11208330-000000000-00000.

PMID:
22133328
9.

Tetrabenazine as a cause of neuroleptic malignant syndrome.

Ossemann M, Sindic CJ, Laterre C.

Mov Disord. 1996 Jan;11(1):95. No abstract available.

PMID:
8771075
10.

A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.

Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J.

Clin Neuropharmacol. 2008 May-Jun;31(3):127-33. doi: 10.1097/WNF.0b013e3180ca77ea.

PMID:
18520979
11.

Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

Chen JJ, Ondo WG, Dashtipour K, Swope DM.

Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Review.

PMID:
22749259
12.

Tetrabenazine in the treatment of extrapyramidal dyskinesias.

Gilligan BS, Wodak J, Veale JL, Munro OR.

Med J Aust. 1972 Nov 4;2(19):1054-6. No abstract available.

PMID:
4264609
13.

A randomized trial of amantadine in Huntington disease.

O'Suilleabhain P, Dewey RB Jr.

Arch Neurol. 2003 Jul;60(7):996-8.

PMID:
12873857
14.

Tetrabenazine (Xenazine) for Huntington's chorea.

[No authors listed]

Med Lett Drugs Ther. 2009 Jan 26;51(1304):7-8. Review. No abstract available.

PMID:
19172140
15.

[Editorial: Treatment of choriatic movements].

Nyberg-Hansen R.

Tidsskr Nor Laegeforen. 1975 Nov 30;95(33):1928-30. Norwegian. No abstract available.

PMID:
127403
16.

Post pump chorea in a 77-year-old male.

Saft C, Reber D, Streuer M, Andrich J.

Neurol Sci. 2011 Aug;32(4):699-701. doi: 10.1007/s10072-011-0583-7.

PMID:
21499730
17.

Role of tetrabenazine for Huntington's disease-associated chorea.

Poon LH, Kang GA, Lee AJ.

Ann Pharmacother. 2010 Jun;44(6):1080-9. doi: 10.1345/aph.1M582. Review.

PMID:
20442355
18.
19.

Combined therapy with tetrabenazine and pimozide in Huntington's chorea: pilot study.

McArthur AW, Pollock M, Smidt NA.

N Z Med J. 1976 Feb 25;83(558):114-6.

PMID:
131917
20.

Tetrabenazine.

Hayden MR, Leavitt BR, Yasothan U, Kirkpatrick P.

Nat Rev Drug Discov. 2009 Jan;8(1):17-8. doi: 10.1038/nrd2784. No abstract available.

PMID:
19116624

Supplemental Content

Support Center